Age years | 69.4±0.97 |
Male sex | 57 (73.1%) |
Pack years smoked | 20 (15–150) |
Current smoker | 26 (33.3%) |
Never smoked | 2 (2.6%) |
Tumour stage | |
1a | 18 (23%) |
1b | 25 (32%) |
2a | 14 (18%) |
2b | 3 (4%) |
3a | 17 (22%) |
3b | 1 (1%) |
Cancer death | 17 (21.8%) |
Other cause of death | 23 (29.5%) |
Years of follow up | 7.36 (3.2–9.7) |
Hb g·L−1 | 12.7±0.4 |
Tumour stage 1 | 12.39±0.27 |
Tumour stage 2 | 13.79±0.47 |
Tumour stage 3 | 11.9±0.53 |
Tumour stage 4 | 12.43±0.36 |
Ferritin μg·L−1 | 134.05±13.09 |
Iron μmol·L−1 | 9.86±1.18 |
sTfR mg·L−1 | 2.99±0.07 |
IRP2-positive tumour | 18 (23.1%) |
IRP2 stain intensity | |
Low | 34 (43.6%) |
Medium | 20 (25.6%) |
High | 4 (5.1%) |
IRP2 percentage of tumour positive | 20 (1–100) |
Data are shown as mean±sem, n (%) or median (range), unless otherwise stated.